Apheresis: Basic Principles, Practical Considerations and

More documents

Recommendations

Info

Increase the Yield of Collection • Increase number of CD34 cells - mobilization • Increase volume of blood processed each collection • Increase number of collections
Mobilization of PBSCs Hematopoietic Growth Factors: FDA approved: Granulocyte colony stimulating factor (G-CSF), Granulocyte/macrophage stimulating factor (GM-CSF) Chemotherapy (not for allogeneic donors) HPCs (X20-25) during early hem. Recovery phase after chemotherapy-induced-marrow-aplasia AMD3100 (Mozobil TM , plerixafor) Potent <strong>and</strong> selective inhibitor of CXCR4 Reversible inhibition of the binding of stromaderived factor (SDF-1 ) to its receptor CXCR4
Page 1 and 2:
Apheresis: Basic Principles, Practi
Page 3:
Objectives (Part 2) • Clinical ap
Page 6 and 7:
Apheresis- Mechanism of Action •L
Page 8 and 9:
Separate blood components is based
Page 10 and 11:
Apheresis- Mechanism of Action
Page 12 and 13:
Plasmapheresis/TPE: Fluid Dynamics
Page 15 and 16: Technology •Automated centrifugal
Page 17 and 18: Use of Apheresis (cont.) Therapeuti
Page 19 and 20: Apheresis Procedural Elements (+ Pr
Page 21 and 22: Venous Access *Apheresis require la
Page 25 and 26: Replacement Fluid *The primary func
Page 27 and 28: Comparison of Replacement Fluids Re
Page 31 and 32: Volume of Patient Plasma Exchanged
Page 33 and 34: Normal/abnormal Constituents Remove
Page 37 and 38: Anticoagulation
Page 39 and 40: Patient History and Medications •
Page 41 and 42: ACE inhibitors A.C.E. Inhibitor Ang
Page 45 and 46: Interval between Exchanges : Why we
Page 47 and 48: Complications 1) Hypotension S/S: l
Page 49 and 50: 4) Allergic reaction: Complications
Page 51 and 52: Journal of Clinical Apheresis 16:3,
Page 53 and 54: Blood/Plasma Volume Calculations
Page 55 and 56: TBV - Nadler’s Formula
Page 57 and 58: Estimated Blood Volume
Page 59 and 60: Treatment Dosage A “typical” or
Page 61 and 62: Hematopoietic Stem Cells Transplant
Page 63 and 64: HSCs Quantification: Why CD34 CD34
Page 65: In Steady State • HPCs circulatin
Page 69 and 70: Hematopoietic Growth Factors - CD34
Page 71 and 72: Hematopoietic Growth Factors - CD34
Page 73 and 74: HPC Collections -Technical Aspects
Page 75 and 76: Post Collection Donor Issues • Pl
Page 77: Post Collection Donor Issues G-CSF
show all

Apheresis: Basic Principles, Practical Considerations and

Create successful ePaper yourself

Delete template?

Save as template?